NHS GGC Thromboprophylaxis Guidelines for COVID-19 patients are now available.
Thromboprophylaxis in COVID-19 Patients
Posted: Friday, April 24, 2020
Category - Medicines Update
For all healthcare professionals across NHSGGC both in primary care and the acute sector.
Please note, Medicines Update blogs are correct at the time of publication.
Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact medicines.update@ggc.scot.nhs.uk.
Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC resposnsible for the development of Medicines Update.
If you would like to contribute to Medicines Update, click here for a guide to blog writing and the checklist to complete prior to submitting a blog to the Communications Subcommittee of ADTC.
Posted: Friday, April 24, 2020
Category - Medicines Update
NHS GGC Thromboprophylaxis Guidelines for COVID-19 patients are now available.
Posted: Wednesday, April 22, 2020
Category - Medicines Update
Esmya (ulipristal acetate): suspension of the licence due to ri...
Posted: Wednesday, April 22, 2020
Category - Medicines Update
NHS GGC Guidance: Conversion from warfarin to a direct oral anticoagulant (DOAC) during hospital admission for patients with non-valvular atrial fibrillation* (AF) or venous thromboembolism (VTE) * non-valvular AF exclu...
Posted: Wednesday, April 22, 2020
Category - Medicines Update
Key messages: Following a review, the Commission on Human Medicines’ Expert Working Group on coronavirus (COVID-19) concluded that there is currently insufficient evidence to establish a link between use of...
Posted: Wednesday, April 22, 2020
Category - Medicines Update
COVID-19 NHSGGC Guidelines relating to medicines published between 13th and 17th April New Adult NHSGGC Guidelines now available on StaffNet
Posted: Wednesday, December 18, 2019
Category - Medicines Update
Alfentanil is an injectable strong opioid which is 30 times stronger than oral morphine. It is used, following specialist advice, for moderate to severe opioid responsive pain in palliative patients with stage 4-5 chronic kidney disease (eGFR ...
Posted: Tuesday, February 19, 2019
Category - Medicines Update
Are you acting in compliance with the pregnancy prevention measures? Previous Medicines Update blogs have highlighted the
Posted: Friday, May 18, 2018
Category - Medicines Update
New drug safety advice from the MHRA regarding
Posted: Thursday, May 3, 2018
Category - Medicines Update
Important new drug safety information from the MHRA regarding